The National Institutes of Health's National Center for Advancing Translational Sciences awarded a $913,177 delivery order against its CRO Support for NCATS In Vitro and In Vivo Toxicology Studies master IDIQ contract to IIT Research Institute. IIT Research Institute, operating as the research and programs division of the Illinois Institute of Technology, will conduct three-month subcutaneous toxicity studies in dogs and mice to support the Center's drug development programs. Performance will...
This is a $2,495,455.00 delivery order awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency, to the IIT Research Institute (IITRI), a non-profit contract research organization and division of the Illinois Institute of Technology. The contract is for non-clinical safety assessment of a covalent bi-tox compound to support a neuropathic pain indication. This delivery order is part of a larger $48.6 million multiple-award CRO Support for NCATS In Vitro and...
This is a $2,567,101.00 delivery order awarded by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response to IIT Research Institute, a non-profit division of Illinois Institute of Technology. The contract is for preclinical drug testing services, including pharmacology, toxicology, and safety evaluations, to support Investigational New Drug applications across therapeutic areas such as cancer, neurology, and neglected diseases. The...
This is a $2,561,491.00 delivery order awarded by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response to the IIT Research Institute, a non-profit research arm of the Illinois Institute of Technology. The contract supports preclinical drug testing services, including pharmacology, toxicology, and safety testing, to generate data for Investigational New Drug applications across therapeutic areas such as cancer, neurology, and...
This federal contract award was made by the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health, to the IIT Research Institute (IITRI), a non-profit contract research organization. The $119,495.00 firm fixed-price Purchase Order is for a 14-day dose range finding study in mice to support Investigational New Drug (IND) applications. IITRI has extensive experience conducting preclinical drug development services, including toxicology,...
This is a $1,790,042.00 Delivery Order Contract awarded by the National Cancer Institute (NCI) to the IIT Research Institute (IITRI), a non-profit subsidiary of the Illinois Institute of Technology (IIT). The contract is for toxicology studies in mice and dogs administered MTX-531, which does not have a set-aside designation. IITRI is a leading preclinical contract research organization that specializes in providing drug development services to federal agencies like the NCI, NIAID, NINDS, and...
This is a federal contract awarded by the U.S. Department of Health and Human Services (HHS) to the Illinois Institute of Technology Research Institute (IITRI), a non-profit contract research organization. The contract, valued at $231,502, is for preclinical toxicology studies of chemopreventive agents in dogs under work order #62. The contract is a definitive, firm-fixed price contract with a completion date of June 30, 2005. IITRI specializes in conducting pharmacology, toxicology, safety, and...
This is a cost-plus-fixed-fee delivery order awarded by the Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences to IIT Research Institute, a non-profit research and technology development organization, to conduct non-clinical safety assessments of acoziborole (SCYX-7158) to support human African trypanosomiasis (HAT) drug development. The $1,156,165.39 delivery order is under the "CRO Support for NCATS In Vitro and In...
The National Cancer Institute (NCI) awarded a $1,886,133.00 delivery order contract to the IIT Research Institute (IITRI), a non-profit division of the Illinois Institute of Technology. The contract is for toxicology studies in rats and dogs administered the compound AIT-102. The award is not associated with a set-aside designation. IITRI is a contract research organization that specializes in preclinical drug development services, including pharmacology, toxicology, safety, and efficacy...
This federal contract award, valued at $698,236.00, was issued to the Illinois Institute of Technology Research Institute (IITRI), a non-profit organization, by a U.S. government agency. The contract is a Definitive Contract with a Firm Fixed Price pricing type. It does not have a set-aside designation. IITRI is a preclinical contract research organization (CRO) that provides a wide range of services to pharmaceutical, biotechnology, and government clients, including the National Institutes of...